DIN 02243763 — COMTAN 200 MG
COMTAN is a tablet of Entacapone marketed by SANDOZ CANADA INCORPORATED. The full Entacapone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02243763
- Brand name
- COMTAN
- Active ingredient
- Entacapone
- Strength
- 200 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- DORMANT
- Drug class
- Catechol-O-methyltransferase (COMT) inhibitor - antiparkinsonian agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Entacapone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02535939 | MINT-ENTACAPONE | 200 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02380005 | SANDOZ ENTACAPONE | 200 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02375559 | TEVA-ENTACAPONE | 200 MG | TABLET | TEVA CANADA LIMITED | MARKETED |